Tessa Romero
Stock Analyst at JP Morgan
(1.62)
# 1518
Out of 5,370 analysts
66
Total ratings
48.94%
Success rate
23.18%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CYTK Cytokinetics | Maintains: Overweight | 71 53 | 33.75 | 57.04% | 5 | Jun 9, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Overweight | 26 30 | 22.12 | 35.62% | 7 | Jun 6, 2025 | |
LXEO Lexeo Therapeutics | Maintains: Overweight | 16 10 | 3.95 | 153.16% | 2 | May 30, 2025 | |
DYN Dyne Therapeutics | Maintains: Neutral | 18 17 | 13.81 | 23.1% | 5 | Mar 21, 2025 | |
BHVN Biohaven | Maintains: Overweight | 72 68 | 15.15 | 348.84% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 38 | 11.21 | 238.98% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 15 | 0.87 | 1624.14% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 31 | 32.15 | -3.58% | 5 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 32 29 | 8.88 | 226.58% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 31 | 14.66 | 111.46% | 8 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Neutral | 46 | 35.5 | 29.58% | 6 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 8 7 | 4.91 | 42.57% | 5 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 54 55 | 32.07 | 71.5% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 39 36 | n/a | n/a | 4 | Jun 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 140 150 | n/a | n/a | 1 | Mar 2, 2021 |